1860-41-9Relevant articles and documents
CYCLOALKYL-CONTAINING CARBOXYLIC ACIDS AND USES THEREOF
-
Page/Page column 62; 85; 86, (2021/06/26)
The present application discloses a compound of formula (I) or a salt thereof: (I) and compositions comprising such compound or salt thereof. The use of such compound, salt thereof or composition comprising same for treating anemia or leukopenia, fibrosis, cancer, hypertension and/or a metabolic condition in a subject is also disclosed.
DIARYL ETHERS AS OPIOID RECEPTOR ANTAGONIST
-
Page/Page column 88, (2008/06/13)
A compound of the formula (I) wherein the variables X1 to X10, R1 to R7 including R3', E, v, y, z, A and B are as described, or a pharmaceutically acceptable salt, solvate, enantiomer, racemate, diastereomer or mixtures thereof, useful for the treatment, prevention or amelioration of obesity and Related Diseases is disclosed.
Is a nitrogen atom an important pharmacophoric element in sigma ligand binding?
Ablordeppey, Seth Y.,Fischer, James B.,Glennon, Richard A.
, p. 2105 - 2111 (2007/10/03)
A lingering question in σ receptor ligand development is whether a nitrogen atom serves as an important pharmacophoric element in binding affinity. To address this question, we have synthesized several phenylalkylpiperidines and phenylalkylpiperazines and
